- Raised $20M funding round, Oct 2020
- Raised funding round, May 2024
About
Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe, and residual-free therapies for animal and human health.
Mileutis has developed a line of biopharmaceuticals that are revolutionizing the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics.
The company's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows. Mileutis's products aim to replace antibiotics in dairy farms, improve cow wellbeing, and provide additional and significant economic value to farmers by increasing milk yield and productivity.
Funding history · 2 rounds · $20.0M total
Q&A
- What is Mileutis's primary focus?
- Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel, biologically sourced, safe, and residual-free therapies for animal and human health.
- What are Mileutis's lead products?
- Mileutis's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows.
- How do Mileutis's products aim to impact animal health?
- Mileutis's products aim to replace antibiotics in dairy farms, improve cow well-being, and provide economic value to farmers by increasing milk yield and productivity.
- What is the total amount of funding Mileutis has raised?
- Mileutis has raised a total of $20,000,000 in funding.
- When was Mileutis's most recent funding round?
- Mileutis's most recent funding round occurred in May 2024, with participation from Yotvata Dairy.
- Which investor participated in Mileutis's October 2020 funding round?
- NovaQuest Capital Management participated in Mileutis's funding round in October 2020.
- What is Mileutis's employee count?
- Mileutis has an employee count in the 11-50 range.
- Where is Mileutis's headquarters located?
- Mileutis's headquarters is located in Ness Ziona, Center District, Israel.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | mileutis.com |
|---|---|
| linkedin.com/company/28138649 |
Identifiers & details
| Founded | 2004-1 |
|---|---|
| Employees (exact) | 32 |
Radar intelligence
Patents
| EPO | 17 |
|---|
Web history (Wayback)
| Domain | mileutis.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|